Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nath, A; Maragos, WF; Avison, MJ; Schmitt, FA; Berger, JR
   Acceleration of HIV dementia with methamphetamine and cocaine
   JOURNAL OF NEUROVIROLOGY
   
   A. Nath et al., "Acceleration of HIV dementia with methamphetamine and cocaine", J NEUROVIRO, 7(1), 2001, pp. 66-71
2. Cadet, JL
   Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice
   PARKINSONISM & RELATED DISORDERS
   
   J.L. Cadet, "Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice", PARKINS R D, 8(2), 2001, pp. 85-90
3. Mora, F; del Arco, A; Segovia, G
   Endogenous interaction of glutamate and dopamine in the basal ganglia of the awake rat during aging
   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
   
   F. Mora et al., "Endogenous interaction of glutamate and dopamine in the basal ganglia of the awake rat during aging", J PHYSIOL B, 57(2), 2001, pp. 97-104
4. Laruelle, M; Huang, Y
   Vulnerability of Positron Emission Tomography radiotracers to endogenous competition - New insights
   QUARTERLY JOURNAL OF NUCLEAR MEDICINE
   
   M. Laruelle e Y. Huang, "Vulnerability of Positron Emission Tomography radiotracers to endogenous competition - New insights", Q J NUCL M, 45(2), 2001, pp. 124-138
5. Olsson, H; Farde, L
   Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulationstudy based on experimental data
   NEUROIMAGE
   
   H. Olsson e L. Farde, "Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulationstudy based on experimental data", NEUROIMAGE, 14(4), 2001, pp. 936-945
6. Moresco, RM; Messa, C; Lucignani, G; Rizzo, G; Todde, S; Gilardi, MC; Grimaldi, A; Fazio, F
   Pet in psychopharmacology
   PHARMACOLOGICAL RESEARCH
   
   R.M. Moresco et al., "Pet in psychopharmacology", PHARMAC RES, 44(3), 2001, pp. 151-159
7. Barrett, T; Xie, T; Piao, Y; Dillon-Carter, O; Kargul, GJ; Lim, MK; Chrest, FJ; Wersto, R; Rowley, DL; Juhaszova, M; Zhou, L; Vawter, MP; Becker, KG; Cheadle, C; Wood, WH; McCann, UD; Freed, WJ; Ko, MS; Ricaurte, GA; Donovan, DM
   A murine dopamine neuron-specific cDNA library and microarray: Increased COXI expression during methamphetamine neurotoxicity
   NEUROBIOLOGY OF DISEASE
   
   T. Barrett et al., "A murine dopamine neuron-specific cDNA library and microarray: Increased COXI expression during methamphetamine neurotoxicity", NEUROBIOL D, 8(5), 2001, pp. 822-833
8. Borlongan, CV; Zhou, FC; Hayashi, T; Su, TP; Hoffer, BJ; Wang, Y
   Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats
   NEUROBIOLOGY OF DISEASE
   
   C.V. Borlongan et al., "Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats", NEUROBIOL D, 8(4), 2001, pp. 636-646
9. Yoneda, F; Moto, T; Sakae, M; Ohde, H; Knoll, B; Miklya, I; Knoll, J
   Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
   BIOORGANIC & MEDICINAL CHEMISTRY
   
   F. Yoneda et al., "Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain", BIO MED CH, 9(5), 2001, pp. 1197-1212
10. Vanderschuren, LJMJ; De Vries, TJ; Wardeh, G; Hogenboom, FACM; Schoffelmeer, ANM
    A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    L.J.M.J. Vanderschuren et al., "A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats", EUR J NEURO, 14(9), 2001, pp. 1533-1538
11. Pallis, E; Thermos, K; Spyraki, C
    Chronic desipramine treatment selectively potentiates somatostatin-induceddopamine release in the nucleus accumbens
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    E. Pallis et al., "Chronic desipramine treatment selectively potentiates somatostatin-induceddopamine release in the nucleus accumbens", EUR J NEURO, 14(4), 2001, pp. 763-767
12. Baunez, C; Humby, T; Eagle, DM; Ryan, LJ; Dunnett, SB; Robbins, TW
    Effects of STN lesions on simple vs choice reaction time tasks in the rat:preserved motor readiness, but impaired response selection
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    C. Baunez et al., "Effects of STN lesions on simple vs choice reaction time tasks in the rat:preserved motor readiness, but impaired response selection", EUR J NEURO, 13(8), 2001, pp. 1609-1616
13. David, HN; Abraini, JH
    The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D-1-like, but not D-2-like, dopamine receptors in the rat nucleus accumbens
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    H.N. David e J.H. Abraini, "The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D-1-like, but not D-2-like, dopamine receptors in the rat nucleus accumbens", EUR J NEURO, 13(11), 2001, pp. 2157-2164
14. Verhoeff, NPLG
    Imaging of dopaminergic transmission in neuropsychiatric disorders
    CURRENT OPINION IN PSYCHIATRY
    
    N.P.L.G. Verhoeff, "Imaging of dopaminergic transmission in neuropsychiatric disorders", CUR OPIN P, 14(3), 2001, pp. 227-239
15. Halladay, AK; Kirschner, E; Hesse, K; Fisher, H; Wagner, GC
    Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release
    PHARMACOLOGY & TOXICOLOGY
    
    A.K. Halladay et al., "Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release", PHARM TOX, 89(5), 2001, pp. 237-248
16. Castagnoli, KP; Steyn, SJ; Petzer, JP; Van der Schyf, CJ; Castagnoli, N
    Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco
    CHEMICAL RESEARCH IN TOXICOLOGY
    
    K.P. Castagnoli et al., "Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco", CHEM RES T, 14(5), 2001, pp. 523-527
17. El-Khodor, B; Boksa, P
    Caesarean section birth produces long term changes in dopamine D1 receptors and in stress-induced regulation of D3 and D4 receptors in the rat brain
    NEUROPSYCHOPHARMACOLOGY
    
    B. El-Khodor e P. Boksa, "Caesarean section birth produces long term changes in dopamine D1 receptors and in stress-induced regulation of D3 and D4 receptors in the rat brain", NEUROPSYCH, 25(3), 2001, pp. 423-439
18. Walker, QD; Cabassa, J; Kaplan, KA; Li, ST; Haroon, J; Spohr, HA; Kuhn, CM
    Sex differences in cocaine-stimulated motor behavior: Disparate effects ofgonadectomy
    NEUROPSYCHOPHARMACOLOGY
    
    Q.D. Walker et al., "Sex differences in cocaine-stimulated motor behavior: Disparate effects ofgonadectomy", NEUROPSYCH, 25(1), 2001, pp. 118-130
19. Okauchi, T; Suhara, T; Maeda, J; Kawabe, K; Obayashi, S; Suzuki, K
    Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET
    SYNAPSE
    
    T. Okauchi et al., "Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET", SYNAPSE, 41(2), 2001, pp. 87-95
20. Wallace, TL; Gudelsky, GA; Vorhees, CV
    Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat
    SYNAPSE
    
    T.L. Wallace et al., "Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat", SYNAPSE, 39(1), 2001, pp. 1-7
21. Winogrodzka, A; Wagenaar, RC; Bergmans, P; Vellinga, A; Booij, J; van Royen, EA; van Emmerik, REA; Stoof, JC; Wolters, EC
    Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients
    MOVEMENT DISORDERS
    
    A. Winogrodzka et al., "Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients", MOVEMENT D, 16(6), 2001, pp. 1033-1040
22. Bowyer, JF; Hopkins, KJ; Jakab, R; Ferguson, SA
    L-ephedrine-induced neuro degeneration in the parietal cortex and thalamusof the rat is dependent on hyperthermia and can be altered by the process of in vivo brain microdialysis
    TOXICOLOGY LETTERS
    
    J.F. Bowyer et al., "L-ephedrine-induced neuro degeneration in the parietal cortex and thalamusof the rat is dependent on hyperthermia and can be altered by the process of in vivo brain microdialysis", TOX LETT, 125(1-3), 2001, pp. 151-166
23. Frey, KA
    The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease
    ANNALS OF NEUROLOGY
    
    K.A. Frey, "The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease", ANN NEUROL, 49(3), 2001, pp. 285-287
24. Petroske, E; Meredith, GE; Callen, S; Totterdell, S; Lau, YS
    Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
    NEUROSCIENCE
    
    E. Petroske et al., "Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment", NEUROSCIENC, 106(3), 2001, pp. 589-601
25. Gajendiran, M; Ling, GY; Pang, Z; Xu, ZC
    Differential changes of synaptic transmission in spiny neurons of rat neostriatum following transient forebrain ischemia
    NEUROSCIENCE
    
    M. Gajendiran et al., "Differential changes of synaptic transmission in spiny neurons of rat neostriatum following transient forebrain ischemia", NEUROSCIENC, 105(1), 2001, pp. 139-152
26. Gao, X; Dluzen, DE
    Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamineneurotoxicity of the nigrostriatal dopaminergic system
    NEUROSCIENCE
    
    X. Gao e D.E. Dluzen, "Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamineneurotoxicity of the nigrostriatal dopaminergic system", NEUROSCIENC, 103(2), 2001, pp. 385-394
27. Rothblat, DS; Rubin, E; Schneider, JS
    Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat
    NEUROSCIENCE LETTERS
    
    D.S. Rothblat et al., "Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat", NEUROSCI L, 300(2), 2001, pp. 63-66
28. Zucker, M; Weizman, A; Harel, D; Rehavi, M
    Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs
    NEUROPSYCHOBIOLOGY
    
    M. Zucker et al., "Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs", NEUROPSYCHB, 44(4), 2001, pp. 187-191
29. Thiel, CM; Schwarting, RKW
    Dopaminergic lateralisation in the forebrain: Relations to behavioural asymmetries and anxiety in male Wistar rats
    NEUROPSYCHOBIOLOGY
    
    C.M. Thiel e R.K.W. Schwarting, "Dopaminergic lateralisation in the forebrain: Relations to behavioural asymmetries and anxiety in male Wistar rats", NEUROPSYCHB, 43(3), 2001, pp. 192-199
30. Delforge, J; Bottlaender, M; Pappata, S; Loc'h, C; Syrota, A
    Absolute quantification by positron emission tomography of the endogenous ligand
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    J. Delforge et al., "Absolute quantification by positron emission tomography of the endogenous ligand", J CEREBR B, 21(5), 2001, pp. 613-630
31. Letchworth, SR; Nader, MA; Smith, HR; Friedman, DP; Porrino, LJ
    Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys
    JOURNAL OF NEUROSCIENCE
    
    S.R. Letchworth et al., "Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys", J NEUROSC, 21(8), 2001, pp. 2799-2807
32. Binder, EB; Kinkead, B; Owens, MJ; Kilts, CD; Nemeroff, CB
    Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: Evidence from animal models of sensorimotor gating
    JOURNAL OF NEUROSCIENCE
    
    E.B. Binder et al., "Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: Evidence from animal models of sensorimotor gating", J NEUROSC, 21(2), 2001, pp. 601-608
33. Okada, M; Nutt, DJ; Murakami, T; Zhu, G; Kamata, A; Kawata, Y; Kaneko, S
    Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release
    JOURNAL OF NEUROSCIENCE
    
    M. Okada et al., "Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release", J NEUROSC, 21(2), 2001, pp. 628-640
34. Galea, LAM; Wide, JK; Paine, TA; Holmes, MM; Ormerod, BK; Floresco, SB
    High levels of estradiol disrupt conditioned place preference learning, stimulus response learning and reference memory but have limited effects on working memory
    BEHAVIOURAL BRAIN RESEARCH
    
    L.A.M. Galea et al., "High levels of estradiol disrupt conditioned place preference learning, stimulus response learning and reference memory but have limited effects on working memory", BEH BRA RES, 126(1-2), 2001, pp. 115-126
35. Monti, JM; Jantos, H; Monti, D
    Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonists
    BEHAVIOURAL BRAIN RESEARCH
    
    J.M. Monti et al., "Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonists", BEH BRA RES, 123(1), 2001, pp. 23-35
36. Burk, JA; Mair, RG
    Effects of intralaminar thalamic lesions on sensory attention and motor intention in the rat: a comparison with lesions involving frontal cortex and hippocampus
    BEHAVIOURAL BRAIN RESEARCH
    
    J.A. Burk e R.G. Mair, "Effects of intralaminar thalamic lesions on sensory attention and motor intention in the rat: a comparison with lesions involving frontal cortex and hippocampus", BEH BRA RES, 123(1), 2001, pp. 49-63
37. O'Connor, WT
    Functional neuroanatomy of the ventral striopallidal GABA pathway - New sites of intervention in the treatment of schizophrenia
    JOURNAL OF NEUROSCIENCE METHODS
    
    W.T. O'Connor, "Functional neuroanatomy of the ventral striopallidal GABA pathway - New sites of intervention in the treatment of schizophrenia", J NEUROSC M, 109(1), 2001, pp. 31-39
38. Bergstrom, BP; Schertz, KE; Weirick, T; Nafziger, B; Takacs, SA; Lopes, KO; Massa, KJ; Walker, QD; Garris, PA
    Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism
    JOURNAL OF NEUROSCIENCE METHODS
    
    B.P. Bergstrom et al., "Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism", J NEUROSC M, 106(1), 2001, pp. 15-28
39. Shelton, RC; Brown, LL
    Mechanisms of action in the treatment of anxiety
    JOURNAL OF CLINICAL PSYCHIATRY
    
    R.C. Shelton e L.L. Brown, "Mechanisms of action in the treatment of anxiety", J CLIN PSY, 62, 2001, pp. 10-15
40. Wang, GJ; Volkow, ND; Logan, J; Pappas, NR; Wong, CT; Zhu, W; Netusil, N; Fowler, JS
    Brain dopamine and obesity
    LANCET
    
    G.J. Wang et al., "Brain dopamine and obesity", LANCET, 357(9253), 2001, pp. 354-357
41. Weiss, IC; Domeney, AM; Heidbreder, CA; Moreau, JL; Feldon, J
    Early social isolation, but not maternal separation, affects behavioral sensitization to amphetamine in male and female adult rats
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    I.C. Weiss et al., "Early social isolation, but not maternal separation, affects behavioral sensitization to amphetamine in male and female adult rats", PHARM BIO B, 70(2-3), 2001, pp. 397-409
42. Nowend, KL; Arizzi, M; Carlson, BB; Salamone, JD
    D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    K.L. Nowend et al., "D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption", PHARM BIO B, 69(3-4), 2001, pp. 373-382
43. Lynch, WJ; Roth, ME; Mickelberg, JL; Carroll, ME
    Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    W.J. Lynch et al., "Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats", PHARM BIO B, 68(4), 2001, pp. 641-646
44. Byrnes, EM; Byrnes, JJ; Bridges, RS
    Increased sensitivity of dopamine systems following reproductive experience in rats
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    E.M. Byrnes et al., "Increased sensitivity of dopamine systems following reproductive experience in rats", PHARM BIO B, 68(3), 2001, pp. 481-489
45. Khan, GM; Smolders, I; Ebinger, G; Michotte, Y
    2-Chloro-N-6-cyclopentyladenosine-elicited attenuation of evoked glutamaterelease is not sufficient to give complete protection against pilocarpine-induced seizures in rats
    NEUROPHARMACOLOGY
    
    G.M. Khan et al., "2-Chloro-N-6-cyclopentyladenosine-elicited attenuation of evoked glutamaterelease is not sufficient to give complete protection against pilocarpine-induced seizures in rats", NEUROPHARM, 40(5), 2001, pp. 657-667
46. Fowler, JS; Volkow, ND; Logan, J; Franceschi, D; Wang, GJ; MacGregor, R; Shea, C; Garza, V; Pappas, N; Carter, P; Netusil, N; Bridge, P; Liederman, D; Elkashef, A; Rotrosen, J; Hitzemann, R
    Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain
    LIFE SCIENCES
    
    J.S. Fowler et al., "Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain", LIFE SCI, 68(24), 2001, pp. 2759-2768
47. Chapman, DE; Hanson, GR; Kesner, RP; Keefe, KA
    Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    D.E. Chapman et al., "Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine", J PHARM EXP, 296(2), 2001, pp. 520-527
48. Gluck, MR; Moy, LY; Jayatilleke, E; Hogan, KA; Manzino, L; Sonsalla, PK
    Parallel increases in lipid and protein oxidative markers in several mousebrain regions after methamphetamine treatment
    JOURNAL OF NEUROCHEMISTRY
    
    M.R. Gluck et al., "Parallel increases in lipid and protein oxidative markers in several mousebrain regions after methamphetamine treatment", J NEUROCHEM, 79(1), 2001, pp. 152-160
49. Troadec, JD; Marien, M; Darios, F; Hartmann, A; Ruberg, M; Colpaert, F; Michel, PP
    Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress
    JOURNAL OF NEUROCHEMISTRY
    
    J.D. Troadec et al., "Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress", J NEUROCHEM, 79(1), 2001, pp. 200-210
50. Imam, SZ; Ali, SF
    Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia
    JOURNAL OF NEUROCHEMISTRY
    
    S.Z. Imam e S.F. Ali, "Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia", J NEUROCHEM, 78(5), 2001, pp. 952-959
51. Yuan, J; Callahan, BT; McCann, UD; Ricaurte, GA
    Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity
    JOURNAL OF NEUROCHEMISTRY
    
    J. Yuan et al., "Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity", J NEUROCHEM, 77(5), 2001, pp. 1338-1347
52. Callahan, BT; Cord, BJ; Yuan, J; McCann, UD; Ricaurte, GA
    Inhibitors of Na+/H+ and Na+/Ca2+ exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity
    JOURNAL OF NEUROCHEMISTRY
    
    B.T. Callahan et al., "Inhibitors of Na+/H+ and Na+/Ca2+ exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity", J NEUROCHEM, 77(5), 2001, pp. 1348-1361
53. Roedter, A; Winkler, C; Samii, M; Walter, GF; Brandis, A; Nikkhah, G
    Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: Evidence for interhemispheric functional coupling of the two nigrostriatal pathways
    JOURNAL OF COMPARATIVE NEUROLOGY
    
    A. Roedter et al., "Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: Evidence for interhemispheric functional coupling of the two nigrostriatal pathways", J COMP NEUR, 432(2), 2001, pp. 217-229
54. Kuppers, E; Ivanova, T; Karolczak, M; Lazarov, N; Fohr, K; Beyer, C
    Classical and nonclassical estrogen action in the developing midbrain
    HORMONES AND BEHAVIOR
    
    E. Kuppers et al., "Classical and nonclassical estrogen action in the developing midbrain", HORMONE BEH, 40(2), 2001, pp. 196-202
55. Ghorayeb, I; Puschban, Z; Fernagut, PO; Scherfler, C; Rouland, R; Wenning, GK; Tison, F
    Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: A model of early-stage striatonigral degeneration
    EXPERIMENTAL NEUROLOGY
    
    I. Ghorayeb et al., "Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: A model of early-stage striatonigral degeneration", EXP NEUROL, 167(1), 2001, pp. 133-147
56. Bogaert, L; O'Neill, MJ; Moonen, J; Sarre, S; Smolders, I; Ebinger, G; Michotte, Y
    The effects of LY393613, nimodipine and verapamil, in focal cerebral ischaemia
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    L. Bogaert et al., "The effects of LY393613, nimodipine and verapamil, in focal cerebral ischaemia", EUR J PHARM, 411(1-2), 2001, pp. 71-83
57. Murakami, T; Okada, M; Kawata, Y; Zhu, G; Kamata, A; Kaneko, S
    Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T. Murakami et al., "Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis", BR J PHARM, 134(3), 2001, pp. 507-520
58. Richter, A; Hamann, M
    Effects of adenosine receptor agonists and antagonists in a genetic animalmodel of primary paroxysmal dystonia
    BRITISH JOURNAL OF PHARMACOLOGY
    
    A. Richter e M. Hamann, "Effects of adenosine receptor agonists and antagonists in a genetic animalmodel of primary paroxysmal dystonia", BR J PHARM, 134(2), 2001, pp. 343-352
59. Kawata, Y; Okada, M; Murakami, T; Kamata, A; Zhu, G; Kaneko, S
    Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca2+- and K+-evoked serotonin release
    BRITISH JOURNAL OF PHARMACOLOGY
    
    Y. Kawata et al., "Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca2+- and K+-evoked serotonin release", BR J PHARM, 133(4), 2001, pp. 557-567
60. Goettl, VM; Wemlinger, TA; Colvin, AE; Neff, NH; Hadjiconstantinou, M
    Motoric behavior in aged rats treated with GM1
    BRAIN RESEARCH
    
    V.M. Goettl et al., "Motoric behavior in aged rats treated with GM1", BRAIN RES, 906(1-2), 2001, pp. 92-100
61. Fox, CM; Gash, DM; Smoot, MK; Cass, WA
    Neuroprotective effects of GDNF against 6-OHDA in young and aged rats
    BRAIN RESEARCH
    
    C.M. Fox et al., "Neuroprotective effects of GDNF against 6-OHDA in young and aged rats", BRAIN RES, 896(1-2), 2001, pp. 56-63
62. Miyamoto, S; Mailman, RB; Lieberman, JA; Duncan, GE
    Blunted brain metabolic response to ketamine in mice lacking D-1A dopaminereceptors
    BRAIN RESEARCH
    
    S. Miyamoto et al., "Blunted brain metabolic response to ketamine in mice lacking D-1A dopaminereceptors", BRAIN RES, 894(2), 2001, pp. 167-180
63. Gao, XM; Dluzen, DE
    The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system
    BRAIN RESEARCH
    
    X.M. Gao e D.E. Dluzen, "The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system", BRAIN RES, 892(1), 2001, pp. 63-69
64. Sabol, KE; Roach, JT; Broom, SL; Ferreira, C; Preau, MM
    Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo
    BRAIN RESEARCH
    
    K.E. Sabol et al., "Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo", BRAIN RES, 892(1), 2001, pp. 122-129
65. Smith, JCE; Whitton, PS
    The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat
    BRAIN RESEARCH
    
    J.C.E. Smith e P.S. Whitton, "The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat", BRAIN RES, 889(1-2), 2001, pp. 57-62
66. O'Neill, MJ; Hicks, CA; Ward, MA; Osborne, DJ; Wishart, G; Mathews, KS; McLaughlin, DP; Stamford, JA; McCarty, DR; Patrick, KE; Roman, C; Fleisch, JH; Gilmore, J; Boot, JR
    LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia
    BRAIN RESEARCH
    
    M.J. O'Neill et al., "LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia", BRAIN RES, 888(1), 2001, pp. 138-149
67. Avila, MT; Conley, RR; Carpenter, WT
    A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research
    BIOLOGICAL PSYCHIATRY
    
    M.T. Avila et al., "A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research", BIOL PSYCHI, 50(7), 2001, pp. 479-486
68. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
    The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex
    BIOLOGICAL PSYCHIATRY
    
    K.W. Perry et al., "The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex", BIOL PSYCHI, 49(8), 2001, pp. 716-725
69. Kegeles, LS; Laruelle, M; Carlsson, A
    Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor - Reply
    BIOLOGICAL PSYCHIATRY
    
    L.S. Kegeles et al., "Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor - Reply", BIOL PSYCHI, 49(11), 2001, pp. 955-957
70. Trevitt, JT; Carlson, BB; Nowend, K; Salamone, JD
    Substantia nigra pars reticulata is a highly potent site of action for thebehavioral effects of the D1 antagonist SCH 23390 in the rat
    PSYCHOPHARMACOLOGY
    
    J.T. Trevitt et al., "Substantia nigra pars reticulata is a highly potent site of action for thebehavioral effects of the D1 antagonist SCH 23390 in the rat", PSYCHOPHAR, 156(1), 2001, pp. 32-41
71. Olausson, P; Akesson, P; Petersson, A; Engel, JA; Soderpalm, B
    Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat
    PSYCHOPHARMACOLOGY
    
    P. Olausson et al., "Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat", PSYCHOPHAR, 155(4), 2001, pp. 348-361
72. Collins, SL; Edwards, MA; Kantak, KM
    Effects of nitric oxide synthase inhibitors on the discriminative stimuluseffects of cocaine in rats
    PSYCHOPHARMACOLOGY
    
    S.L. Collins et al., "Effects of nitric oxide synthase inhibitors on the discriminative stimuluseffects of cocaine in rats", PSYCHOPHAR, 154(3), 2001, pp. 261-273
73. Wallace, TL; Gudelsky, GA; Vorhees, CV
    Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine
    PSYCHOPHARMACOLOGY
    
    T.L. Wallace et al., "Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine", PSYCHOPHAR, 153(3), 2001, pp. 321-326
74. Worsley, JN; Moszczynska, A; Falardeau, P; Kalasinsky, KS; Schmunk, G; Guttman, M; Furukawa, Y; Ang, L; Adams, V; Reiber, G; Anthony, RA; Wickham, D; Kish, SJ
    Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users
    MOLECULAR PSYCHIATRY
    
    J.N. Worsley et al., "Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users", MOL PSYCHI, 5(6), 2000, pp. 664-672
75. Antelman, SM; Levine, J; Gershon, S
    Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic
    MOLECULAR PSYCHIATRY
    
    S.M. Antelman et al., "Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic", MOL PSYCHI, 5(4), 2000, pp. 350-356
76. Ali, SF; Haung, P; Itzhak, Y
    Role of peroxynitrite in methamphetamine-induced dopaminergic neurotoxicity and sensitization in mice
    ADDICTION BIOLOGY
    
    S.F. Ali et al., "Role of peroxynitrite in methamphetamine-induced dopaminergic neurotoxicity and sensitization in mice", ADDICT BIOL, 5(3), 2000, pp. 331-341
77. Bowyer, JF; Newport, GD; Slikker, W; Gough, B; Ferguson, SA; Tor-Agbidye, J
    An evaluation of I-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate
    TOXICOLOGICAL SCIENCES
    
    J.F. Bowyer et al., "An evaluation of I-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate", TOXICOL SCI, 55(1), 2000, pp. 133-142
78. Joyce, JN; Yoshimoto, K; Ueda, S
    The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system
    NEUROREPORT
    
    J.N. Joyce et al., "The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system", NEUROREPORT, 11(10), 2000, pp. 2173-2175
79. Djano, S; Martin-Iverson, MT
    Does locomotor response to novelty in rats predict susceptibility to develop sensitization to cocaine and PHNO?
    BEHAVIOURAL PHARMACOLOGY
    
    S. Djano e M.T. Martin-Iverson, "Does locomotor response to novelty in rats predict susceptibility to develop sensitization to cocaine and PHNO?", BEHAV PHARM, 11(6), 2000, pp. 455-470
80. Anichtchik, OV; Huotari, M; Peitsaro, N; Haycock, JW; Mannisto, PT; Panula, P
    Modulation of histamine H-3 receptors in the brain of 6-hydroxydopamine-lesioned rats
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    O.V. Anichtchik et al., "Modulation of histamine H-3 receptors in the brain of 6-hydroxydopamine-lesioned rats", EUR J NEURO, 12(11), 2000, pp. 3823-3832
81. Barneoud, P; Descombris, E; Aubin, N; Abrous, DN
    Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    P. Barneoud et al., "Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system", EUR J NEURO, 12(1), 2000, pp. 322-336
82. Martel, JC; Chopin, P; Colpaert, F; Marien, M
    Drug treatments to reduce excitotoxicity in vivo: a potential for alpha 2-adrenoceptor antagonists?
    AMINO ACIDS
    
    J.C. Martel et al., "Drug treatments to reduce excitotoxicity in vivo: a potential for alpha 2-adrenoceptor antagonists?", AMINO ACIDS, 19(1), 2000, pp. 239-252
83. Liechti, ME; Vollenweider, FX
    Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    M.E. Liechti e F.X. Vollenweider, "Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans", EUR NEUROPS, 10(4), 2000, pp. 289-295
84. Mizuno, K; Okada, M; Murakami, T; Kamata, A; Zhu, G; Kawata, Y; Wada, K; Kaneko, S
    Effects of carbamazepine on acetylcholine release and metabolism
    EPILEPSY RESEARCH
    
    K. Mizuno et al., "Effects of carbamazepine on acetylcholine release and metabolism", EPILEPSY R, 40(2-3), 2000, pp. 187-195
85. Fink-Jensen, A
    Novel pharmacological approaches to the treatment of schizophrenia
    DANISH MEDICAL BULLETIN
    
    A. Fink-Jensen, "Novel pharmacological approaches to the treatment of schizophrenia", DAN MED B, 47(3), 2000, pp. 151-167
86. Ornstein, TJ; Iddon, JL; Baldacchino, AM; Sahakian, BJ; London, M; Everitt, BJ; Robbins, TW
    Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
    NEUROPSYCHOPHARMACOLOGY
    
    T.J. Ornstein et al., "Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers", NEUROPSYCH, 23(2), 2000, pp. 113-126
87. Glatt, SJ; Bolanos, CA; Trksak, GH; Jackson, D
    Effects of prenatal cocaine exposure on dopamine system development: a meta-analysis
    NEUROTOXICOLOGY AND TERATOLOGY
    
    S.J. Glatt et al., "Effects of prenatal cocaine exposure on dopamine system development: a meta-analysis", NEUROTOX T, 22(5), 2000, pp. 617-629
88. Passetti, F; Humby, T; Everitt, BJ; Robbins, TW
    Mixed attentional and executive deficits in medial frontal cortex lesionedrats
    PSYCHOBIOLOGY
    
    F. Passetti et al., "Mixed attentional and executive deficits in medial frontal cortex lesionedrats", PSYCHOBIOLO, 28(2), 2000, pp. 261-271
89. O'Dell, SJ; Marshall, JF
    Repeated administration of methamphetamine damages cells in the somatosensory cortex: Overlap with cytochrome oxidase-rich barrels
    SYNAPSE
    
    S.J. O'Dell e J.F. Marshall, "Repeated administration of methamphetamine damages cells in the somatosensory cortex: Overlap with cytochrome oxidase-rich barrels", SYNAPSE, 37(1), 2000, pp. 32-37
90. Kilbourn, MR; Kuszpit, K; Sherman, P
    Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice
    SYNAPSE
    
    M.R. Kilbourn et al., "Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice", SYNAPSE, 35(4), 2000, pp. 250-255
91. Halladay, AK; Fisher, H; Wagner, GC
    Effects of phentermine and fenfluramine on alcohol consumption and alcoholwithdrawal seizures in rats
    ALCOHOL
    
    A.K. Halladay et al., "Effects of phentermine and fenfluramine on alcohol consumption and alcoholwithdrawal seizures in rats", ALCOHOL, 20(1), 2000, pp. 19-29
92. Matuszewich, L; Lorrain, DS; Hull, EM
    Dopamine release in the medial preoptic area of female rats in response tohormonal manipulation and sexual activity
    BEHAVIORAL NEUROSCIENCE
    
    L. Matuszewich et al., "Dopamine release in the medial preoptic area of female rats in response tohormonal manipulation and sexual activity", BEHAV NEURO, 114(4), 2000, pp. 772-782
93. Phillips, JM; Brown, VJ
    Anticipatory errors after unilateral lesions of the subthalamic nucleus inthe rat: Evidence for a failure of response inhibition
    BEHAVIORAL NEUROSCIENCE
    
    J.M. Phillips e V.J. Brown, "Anticipatory errors after unilateral lesions of the subthalamic nucleus inthe rat: Evidence for a failure of response inhibition", BEHAV NEURO, 114(1), 2000, pp. 150-157
94. Segawa, M
    Hereditary progressive dystonia with marked diurnal fluctuation
    BRAIN & DEVELOPMENT
    
    M. Segawa, "Hereditary progressive dystonia with marked diurnal fluctuation", BRAIN DEVEL, 2000, pp. S65-S80
95. Cochiolo, JA; Ehsanian, R; Bruck, DK
    Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    J.A. Cochiolo et al., "Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons", J NEUROSC R, 59(1), 2000, pp. 126-135
96. Donnemiller, E; Brenneis, C; Wissel, J; Scherfler, C; Poewe, W; Riccabona, G; Wenning, GK
    Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPET study using I-123-beta-CIT and I-123-IBZM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    E. Donnemiller et al., "Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPET study using I-123-beta-CIT and I-123-IBZM", EUR J NUCL, 27(9), 2000, pp. 1410-1414
97. Bressan, RA; Pilowsky, LS
    Imaging the glutamatergic system in vivo - relevance to schizophrenia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    R.A. Bressan e L.S. Pilowsky, "Imaging the glutamatergic system in vivo - relevance to schizophrenia", EUR J NUCL, 27(11), 2000, pp. 1723-1731
98. Wolters, EC; Francot, C; Bergmans, P; Winogrodzka, A; Booij, J; Berendse, HW; Stoof, JC
    Preclinical (premotor) Parkinson's disease
    JOURNAL OF NEUROLOGY
    
    E.C. Wolters et al., "Preclinical (premotor) Parkinson's disease", J NEUROL, 247, 2000, pp. 103-109
99. Jenkinson, CP; Hanson, R; Cray, K; Wiedrich, C; Knowler, WC; Bogardus, C; Baier, L
    Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA withobesity or type 2 diabetes mellitus in Pima Indians
    INTERNATIONAL JOURNAL OF OBESITY
    
    C.P. Jenkinson et al., "Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA withobesity or type 2 diabetes mellitus in Pima Indians", INT J OBES, 24(10), 2000, pp. 1233-1238
100. Lu, X; Bing, G; Hagg, T
     Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats
     NEUROSCIENCE
     
     X. Lu et al., "Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats", NEUROSCIENC, 97(2), 2000, pp. 285-291